04:01 PM EST, 02/07/2025 (MT Newswires) -- (Updates with the lender in the first paragraph.) Entero Therapeutics ( ENTO ) got a $2 million revolving loan and appointed three new board members designated by the lender, 1396974 BC Ltd., as a condition for the funding. Richard Paolone, Eric Corbett and Manpreet Uppal replaced James Sapirstein, Alastair Riddell and Timothy Ramdeen...

04:07 PM EST, 02/07/2025 (MT Newswires) -- David Reeder, Chief Financial Officer, on February 05, 2025, sold 107,593 shares in Chewy (CHWY) for $4,094,977. Following the Form 4 filing with the SEC, Reeder has control over a total of 1,087,159 Class A common shares of the company, with 1,087,159 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1766502/000112760225003546/xslF345X05/form4.xml ...

04:07 PM EST, 02/07/2025 (MT Newswires) -- Daniel J Ivascyn, 10% Owner, on February 05, 2025, executed a purchase for 1,000,000 shares in Pimco Flexible Real Estate Income Fund (REFLX) for $10,490,000. Following the Form 4 filing with the SEC, Ivascyn has control over a total of 4,138,497 common shares of the company, with 4,058,889 shares held directly and 79,608...

04:09 PM EST, 02/07/2025 (MT Newswires) -- Mikhail Eydelman, Senior Vice President, General Counsel & Corporate Secretary, on February 05, 2025, sold 5,000 shares in Vaxcyte ( PCVX ) for $450,369. Following the Form 4 filing with the SEC, Eydelman has control over a total of 28,222 common shares of the company, with 28,222 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000012/xslF345X05/wk-form4_1738962245.xml...